Technology and Innovation Improving the FDA: Lessons Learned from COVID-19 Rapid Tests The FDA has a history of delaying decisions, especially when it comes to at-home diagnostic tests. Delays during COVID-19 had real costs.
Technology and Innovation What Policies Promote Abundance? If Congress and other policymakers take the right steps in important areas, then abundance is within reach.
Regulation A New Role for the FDA in Medical Device Regulation This policy paper examines the role of the U.S. Food and Drug Administration in regulating emerging nutrition technologies.